Two Bear Capital
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Selector | Feb 2026Participated | $32 MOther Equity | |
Rainfall Health | Feb 2026Led | $15 MSeries A | |
Revenium | Nov 2025Led | $14 MSeed | |
Gravwell | Oct 2025Led | $15 MSeries A | |
Conceal | Oct 2025Led | $26 MSeries B | |
FYR Bio | Sep 2025Participated | $8 MOther Equity | |
Montara Therapeutics | Mar 2025Participated | $20 MSeed | |
QuSecure | Feb 2025Led | $28 MSeries A | |
Selector | Nov 2024Participated | $33 MSeries B | |
Talus Bio | Aug 2024Led | $11 MSeed | |
Montara Therapeutics | Jul 2024Led | $8 MSeed | |
BINARLY | Mar 2024Led | $11 MSeed | |
Selector | Feb 2026Participated | $32 MOther Equity | |
Rainfall Health | Feb 2026Led | $15 MSeries A | |
Revenium | Nov 2025Led | $14 MSeed | |
Gravwell | Oct 2025Led | $15 MSeries A | |
Conceal | Oct 2025Led | $26 MSeries B | |
FYR Bio | Sep 2025Participated | $8 MOther Equity | |
Montara Therapeutics | Mar 2025Participated | $20 MSeed | |
QuSecure | Feb 2025Led | $28 MSeries A | |
Selector | Nov 2024Participated | $33 MSeries B | |
Talus Bio | Aug 2024Led | $11 MSeed | |
Montara Therapeutics | Jul 2024Led | $8 MSeed | |
BINARLY | Mar 2024Led | $11 MSeed |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 5 | 1 |
| Series A | 10 | 0 |
| Series B | 2 | 2 |
| Other Equity | 3 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jul '20 | 2 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 1 |
| May '21 | 0 |
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 1 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 1 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 0 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 1 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 2 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 1 |
| Mar '25 | 1 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 2 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 2 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 9 |
| Enterprise Software | 8 |
| AI & Machine Learning | 8 |
| Data, Analytics & IT | 8 |
| Cybersecurity & Privacy | 6 |
| Networks, Cloud & Communication | 5 |
| Hardware & Robotics | 2 |
| Space & Frontier Tech | 2 |
| Developer Tools | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 4 |
| $10M-$25M | 10 |
| $25M-$50M | 9 |
| $50M-$100M | 1 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 25 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Atlantic Bridge | 5 |
| SineWave Ventures | 3 |
| AllegisCyber Capital | 2 |
| Ansa Capital | 2 |
| Big Pi Ventures | 2 |
| Dolby Family Ventures | 2 |
| Gula Tech Adventures | 2 |
| Intel Capital | 2 |
| KdT Ventures | 2 |
| Nexus Venture Partners | 2 |
| Sequoia Capital | 2 |
| SV Health Investors | 2 |
| Uncorrelated Ventures | 2 |
| WestWave Capital | 2 |
| Accenture Ventures | 1 |
| Acrobator Ventures | 1 |
| AlleyCorp | 1 |
| Alumni Ventures | 1 |
| Amgen Ventures | 1 |
| AVP | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 20 | 80% |
| Participating | 5 | 20% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 15 | 75% |
| Co-led | 5 | 25% |
Team
Biotechnology Operating Partner
Partner
Operating Partner
Principle
VP, Investor Relations
Partner, Head of Capital Formation
Founder & Managing Partner
Principal